Medicare Enrolled

Dr. Robert Garbacz, D.O.

Dermatology · Wichita Falls, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5 EUREKA CIR STE D, Wichita Falls, TX 76308
9407673376
In practice since 2006 (20 years)
NPI: 1134107360 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Garbacz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garbacz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Garbacz

Dr. Robert Garbacz is a dermatology specialist in Wichita Falls, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Garbacz performed 31,922 Medicare services across 6,329 unique beneficiaries.

Between the years covered by Open Payments, Dr. Garbacz received a total of $4,247 from 26 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Garbacz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in TX $4,247 industry payments

Medicare Practice Summary

Medicare Utilization ↗
31,922
Medicare services
Top 1% in TX for dermatology
6,329
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,596 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Photodynamic therapy gel for precancerous skin 18,600 $1 $4
Destruction of precancerous skin growths, 2-14 2,154 $5 $15
Office visit, established patient (20-29 min) 1,850 $59 $197
Superficial and/or low voltage radiation treatment delivery 1,768 $30 $89
Tissue pathology examination, moderate complexity 1,091 $53 $156
Office visit, established patient (10-19 min) 902 $40 $123
Skin biopsy, tangential 739 $66 $222
Destruction of precancerous skin growth, 1 644 $39 $147
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area 499 $202 $586
Application of ultraviolet light to skin 485 $16 $53
Ultrasonic guidance for placement of radiation therapy fields 355 $135 $392
New patient office visit (30-44 min) 282 $66 $244
Destruction of skin growths (warts/lesions), 1-14 276 $76 $248
Biopsy of related skin growth, each additional growth 268 $38 $110
Calculation of radiation therapy dose 256 $49 $144
Steroid injection (triamcinolone) 234 $1 $2
Design and construction of complex radiation treatment device 194 $94 $273
Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved 130 $330 $984
Office visit, established patient (30-39 min) 114 $82 $280
Application of light with debridement to destroy precancer skin growth 92 $198 $613
New patient office or other outpatient visit, 15-29 minutes 91 $44 $157
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm 80 $204 $666
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm 80 $207 $692
Removal of inflamed or infected skin, up to 10% of body surface 75 $43 $127
Injection into skin growth, 1-7 growths 74 $33 $125
Biopsy of ear 70 $51 $211
Drug injection, under skin or into muscle 61 $9 $31
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm 58 $105 $586
Pathology examination of tissue using a microscope, moderately low complexity 42 $32 $92
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm 35 $138 $423
Destruction of cancer skin growth of trunk, arms, or legs, 3.1-4.0 cm 31 $145 $453
Acne surgery 26 $74 $255
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 26 $95 $536
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 26 $136 $392
Punch biopsy, first skin growth 25 $87 $276
Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm 25 $175 $680
Destruction of precancer skin growth, 15 or more growths 22 $109 $370
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm 21 $152 $452
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm 17 $114 $610
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 16 $142 $414
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 15 $104 $553
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm 13 $66 $376
Destruction of skin growth, 15 or more growths 13 $99 $290
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm 13 $156 $458
New patient office visit (45-59 min) 12 $93 $364
Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, more than 4.0 cm 11 $255 $723
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm 11 $144 $690
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
14.6% medium
85.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,247
Total received (2018-2024)
Avg $607/year across 7 years
Top 46% in TX for dermatology
26
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,058 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$188 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$938
2023
$596
2022
$684
2021
$712
2020
$460
2019
$455
2018
$402

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$798
Lilly USA, LLC
$460
Janssen Biotech, Inc.
$422
Biofrontera Inc.
$359
PFIZER INC.
$301
Novartis Pharmaceuticals Corporation
$258
Sun Pharmaceutical Industries Inc.
$224
GENZYME CORPORATION
$179
SUN PHARMACEUTICAL INDUSTRIES INC.
$165
AbbVie Inc.
$157
E.R. Squibb & Sons, L.L.C.
$150
Celgene Corporation
$138
ABBVIE INC.
$114
Galderma Laboratories, L.P.
$75
Incyte Corporation
$62
AbbVie, Inc.
$55
Verrica Pharmaceuticals Inc.
$54
Dermavant Sciences, Inc.
$54
DUSA Pharmaceuticals, Inc.
$44
Paratek Pharmaceuticals, Inc.
$42
Amgen Inc.
$34
Merck Sharp & Dohme Corporation
$25
Almirall LLC
$23
Regeneron Healthcare Solutions, Inc.
$20
REVANCE THERAPEUTICS, INC.
$19
Genentech USA, Inc.
$17
Top 3 companies account for 39.6% of total payments
Associated products mentioned in payments ›
20% · ABSORICA LD · AKLIEF · AMELUZ · Absorica LD · Ameluz · BLU-U · Bimzelx · COSENTYX · Cimzia · DAXXIFY · DUPIXENT · EPIDUO FORTE · EUCRISA · HUMIRA · Humira · ILUMYA · Ilumya · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · NUZYRA · OPZELURA · Odomzo · Otezla · REMICADE · SIVEXTRO · SKYRIZI · STELARA · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · Xolair · YCANTH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $13 per 100 Medicare services performed
Looking for a dermatology specialist in Wichita Falls?
Compare dermatologists in the Wichita Falls area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
4
Per 100K population
3.1
County median income
$62,168
Nearest hospital
NORTH TEXAS STATE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Garbacz is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Garbacz experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Garbacz performed 18,600 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garbacz receive payments from pharmaceutical companies?
Yes. Dr. Garbacz received a total of $4,247 from 26 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garbacz's costs compare to other dermatologists in Wichita Falls?
Dr. Garbacz's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garbacz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →